Strides Pharma Science Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Strides Pharma Science Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Strides Pharma Science Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Strides Pharma Science Ltd. from all sources in a single place.

Strides Pharma Science Ltd.

11 Nov 2025

973.95

5.39%

STRIDES PHARMA SCIENCE LIMITED

Accumulate: Strides Pharma Science Ltd.

Recommendation Target

Geojit BNP Paribas

Management remains optimistic about performance in other regulated markets, anticipating stronger revenue growth in FY26 as European partners prepare for product launches. The company also expects these markets to eventually generate...

Promoters unpledged 5.97% of shares in last quarter. Total pledge stands at 44.13% of promoter holdings

Strides Pharma Science Ltd.

01 Nov 2025

973.95

5.39%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement - Unaudited financial results of the Company for the quarter and half year ended September 30, 2025

pdf

Strides Pharma Science Ltd.

31 Oct 2025

973.95

5.39%

Strides Pharma Science Q2 net profit jumps 82% at 131.5 crore

Business Line

The company had posted a consolidated net profit of 72.3 crore in the corresponding period last fiscal, Strides Pharma Science said in a regulatory filing

Strides Pharma Scien.. has an average target of 1085.00 from 1 broker.

Strides Pharma Q2FY26 results: Net profit jumps 82% to 131.5 crore

Business Standard | 31 Oct 2025 1 more

Strides Pharma Science Ltd.

31 Oct 2025

973.95

5.39%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Outcome of Board Meeting held on October 31, 2025 - Press Release and Earnings Presentation

pdf

Strides Pharma Science Ltd.

24 Oct 2025

973.95

5.39%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Earnings Call to discuss unaudited financial results of the Company for the quarter and half-year ended September 30, 2025.

pdf

Strides Pharma Science Ltd.

24 Oct 2025

973.95

5.39%

Board Meeting

Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Intimation Regarding Board Meeting Under …

BSE India

Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Strides Pharma Science Ltd.

18 Oct 2025

973.95

5.39%

Strides Founder raises Rs 1000 crore to refinance debt

Economic Times

Arun Kumar, founder of Strides Group and OneSource, has secured 1,000 crore by pledging shares. This move refinances existing loans, extending maturities and simplifying repayments. The transaction aims to consolidate smaller borrowings into larger, long-term facilities. It reflects a broader effort to clean up the promoter's balance sheet and shows a decline in pledged shares, indicating deleveraging.